✨ Free AI Report
Enzymit Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Enzymit Ltd.
Company Research

Enzymit Ltd.: Business Overview, Financials & Competitive Analysis

Enzymit is building a cell-free production platform that aims to make bioproduction faster, simpler, cost-effective, and scalable. The company leverages complex computational design and deep learning algorithms to cre...

Analyst-debate audio for Enzymit Ltd.

AskCyborg analysts argue the bull and bear cases for Enzymit Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

AI-driven synthetic biology platform addressing trillion-dollar biomanufacturing market inefficiencies with defensible...

Read the full analyst-debate transcript →
Industry Industrial Biotechnology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Enzymit Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Enzymit Ltd. Overview

Pro stress-test →

Enzymit is building a cell-free production platform that aims to make bioproduction faster, simpler, cost-effective, and scalable. The company leverages complex computational design and deep learning algorithms to create novel enzymes for real-world applications. Its proprietary technology enables sustainable, localized biochemical manufacturing across pharmaceuticals, cosmetics, foodtech, and materials.

Strategic Profile

Pro stress-test →

Enzymit is developing cell-free bio-production technology eliminating inefficiencies, complexity and cost of current bio-production technologies, with small, modular bio-reactors that can efficiently convert available feedstocks into valuable products. The AI-powered platform designs entirely new enzymes tailored for specific production challenges, enabling creation of molecules and materials previously unattainable or prohibitively costly to produce.

Competitive Landscape

Pro stress-test →

Enzymit competes in synthetic biology and cell-free bioproduction against established biotech contract manufacturers (Lonza, Samsung BioLogics), emerging enzyme-design platforms (Genentech, DNA Script), and traditional fermentation-based biotech. Enzymit's competitive edge rests on AI-powered custom enzyme design enabling rapid optimization and cost reduction for niche, high-value syntheses.

Industry Context

Enzymit Ltd. operates in Industrial Biotechnology.

Key facts

Founded: 2020 · Headquarters: Ness Ziona, Israel · Employees: 11–50 · Revenue: Estimated early-stage; not disclosed · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Enzymit Ltd..

  • Enzymit closed a $10 million Series A funding round led by Grove Ventures and Khosla Ventures in September 2024, validating cell-free production technology and de-risking path to commercialization for applications spanning pharma, cosmetics, and food.
  • Enzymit demonstrated success in synthetically producing hyaluronic acid for cosmetic and therapeutic applications using computational protein design and deep learning, creating highly stable enzymes that withstand higher temperatures and work longer for efficient production.
+1 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2024$10 million Series A funding round closed led by Grove Ventures and Khosla Ventures
  • August 2023Published peer-reviewed study on deep learning-based enzyme design efficacy
  • +1 moreTrack every material event for Enzymit Ltd. as it happens. Explore monitoring →
Get alerted when Enzymit Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

DNA ScriptEnzymatic DNA synthesis platform→Ansa BiotechnologiesEnzymatic nucleic acid synthesis platform for ultra-long DNA synthesis→Twist BioscienceEnzymatic DNA synthesis and synthetic biology platform→

Compare Enzymit Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Enzymit Ltd. operates in Industrial Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Browse Industrial Biotechnology research →
NEW · MCP server

Ask your AI assistant about Enzymit Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Enzymit Ltd. and its top competitor on Cyborg Score”
“What did Enzymit Ltd. do this quarter?”
“Is Enzymit Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Enzymit Ltd. do?+
Enzymit is building a cell-free production platform that aims to make bioproduction faster, simpler, cost-effective, and scalable. The company leverages complex computational design and deep learning algorithms to cre...
What is Enzymit Ltd.'s Cyborg Score?+
Enzymit Ltd. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Enzymit Ltd.'s main competitors?+
Named competitors include DNA Script, Ansa Biotechnologies, Twist Bioscience. The full competitive landscape is in the AskCyborg report.
How can I get the full Enzymit Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Enzymit Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Enzymit Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Industrial Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

4BRAIN Biotech AG4Fermentalg